Price T Rowe Associates Inc Amphastar Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 273,288 shares of AMPH stock, worth $8.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273,288
Previous 541,221
49.51%
Holding current value
$8.29 Million
Previous $15.7 Million
60.01%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
32.9MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$81.5 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$61.8 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$49.4 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$47.8 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.49B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...